Development of radiochemical labelling process
We take your lead compound from paper to reality and develop a robust and GMP compliant automated synthesis process. Our core competence is finding the optimal radiochemical labelling conditions of your lead compound with a variety of radionuclides (F-18, Ga-68, Lu-177, I-123, …), followed by its purification and formulation to a Drug Product. Development includes stability and formulation studies to provide a safe and stable solution for the patient.
With six hot cells dedicated for development and the largest variety of radiopharmaceutical synthesizers in the world, we are a frontrunner when it comes to radiopharmaceuticals. For us, quality already starts in development. Our developmental facility is equipped with state-of-the-art Quality Control equipment to ensure development of robust Quality Control methods.